CSL Limited CSL.AX Stock
278.09 AUD
{{ price }}
0.165685%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Australia
Exchange
ASX
Market Cap
134.39B AUD
LOW - HIGH [24H]
277.2
-
280.1 AUD
VOLUME [24H]
520.89K AUD
{{ volume }}
P/E Ratio
36.49
Earnings per share
7.62 AUD
CSL Limited Price Chart
CSL Limited CSL.AX Financial and Trading Overview
| CSL Limited stock price | 278.09 AUD |
| Previous Close | 279.5 AUD |
| Open | 277.9 AUD |
| Bid | 277.8 AUD x 0 |
| Ask | 278 AUD x 0 |
| Day's Range | 274.8 - 279.88 AUD |
| 52 Week Range | 254.3 - 314.28 AUD |
| Volume | 2.94M AUD |
| Avg. Volume | 672.75K AUD |
| Market Cap | 137.75B AUD |
| Beta (5Y Monthly) | 0.217241 |
| PE Ratio (TTM) | 44.60032 |
| EPS (TTM) | 7.62 AUD |
| Forward Dividend & Yield | 3.38 (1.17%) |
| Ex-Dividend Date | March 9, 2023 |
| 1y Target Est | 324.01 AUD |
CSL.AX Valuation Measures
| Enterprise Value | 151.33B AUD |
| Trailing P/E | 44.60032 |
| Forward P/E | 29.559574 |
| PEG Ratio (5 yr expected) | 1.23 |
| Price/Sales (ttm) | 11.769058 |
| Price/Book (mrq) | 8.547434 |
| Enterprise Value/Revenue | 12.93 |
| Enterprise Value/EBITDA | 43.917 |
Trading Information
CSL Limited Stock Price History
| Beta (5Y Monthly) | 0.217241 |
| 52-Week Change | 9.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 314.28 AUD |
| 52 Week Low | 254.3 AUD |
| 50-Day Moving Average | 303.21 AUD |
| 200-Day Moving Average | 293.31 AUD |
CSL.AX Share Statistics
| Avg. Volume (3 month) | 672.75K AUD |
| Avg. Daily Volume (10-Days) | 944.53K AUD |
| Shares Outstanding | 482.37M |
| Float | 481.13M |
| Short Ratio | N/A |
| % Held by Insiders | 0.40% |
| % Held by Institutions | 35.00% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.25 |
| Trailing Annual Dividend Yield | 0.80% |
| 5 Year Average Dividend Yield | 106.00% |
| Payout Ratio | 0.5157 |
| Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 18.09% |
| Operating Margin (ttm) | 25.38% |
| Gross Margin | 52.52% |
| EBITDA Margin | 29.44% |
Management Effectiveness
| Return on Assets (ttm) | 6.30% |
| Return on Equity (ttm) | 13.37% |
Income Statement
| Revenue (ttm) | 11.7B AUD |
| Revenue Per Share (ttm) | 24.31 AUD |
| Quarterly Revenue Growth (yoy) | 18.89% |
| Gross Profit (ttm) | 5.73B AUD |
| EBITDA | 3.45B AUD |
| Net Income Avi to Common (ttm) | 2.12B AUD |
| Diluted EPS (ttm) | 6.23 |
| Quarterly Earnings Growth (yoy) | -7.79% |
Balance Sheet
| Total Cash (mrq) | 1.51B AUD |
| Total Cash Per Share (mrq) | 3.13 AUD |
| Total Debt (mrq) | 12.12B AUD |
| Total Debt/Equity (mrq) | 67.77 AUD |
| Current Ratio (mrq) | 2.218 |
| Book Value Per Share (mrq) | 32.508 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.18B AUD |
| Levered Free Cash Flow (ttm) | -113812496 AUD |
Profile of CSL Limited
| Country | Australia |
| State | VIC |
| City | Parkville |
| Address | 45 Poplar Road |
| ZIP | 3052 |
| Phone | 61 3 9389 1911 |
| Website | https://www.csl.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 30000 |
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Q&A For CSL Limited Stock
What is a current CSL.AX stock price?
CSL Limited CSL.AX stock price today per share is 278.09 AUD.
How to purchase CSL Limited stock?
You can buy CSL.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CSL Limited?
The stock symbol or ticker of CSL Limited is CSL.AX.
Which industry does the CSL Limited company belong to?
The CSL Limited industry is Biotechnology.
How many shares does CSL Limited have in circulation?
The max supply of CSL Limited shares is 483.25M.
What is CSL Limited Price to Earnings Ratio (PE Ratio)?
CSL Limited PE Ratio is 36.49475000 now.
What was CSL Limited earnings per share over the trailing 12 months (TTM)?
CSL Limited EPS is 7.62 AUD over the trailing 12 months.
Which sector does the CSL Limited company belong to?
The CSL Limited sector is Healthcare.
CSL Limited CSL.AX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| S&P/ASX 300 AXKO | 7796.8 AUD 5160.37 USD |
-0.05
|
— — | 7796.8 AUD 5160.37 USD | 7828.6 AUD 5181.42 USD | — - | — — |
| S&P/ASX 200 EQUAL WEIGHT AXEW | 1896 AUD 1254.88 USD |
-0.41
|
— — | 1894.1 AUD 1253.62 USD | 1909.8 AUD 1264.01 USD | — - | — — |
| S&P/ASX ALL AUSTRALIAN 50 AXAF | 7748.8 AUD 5128.6 USD |
+0.04
|
— — | 7745.4 AUD 5126.35 USD | 7775.1 AUD 5146.01 USD | — - | — — |
| S&P/ASX 20 ATLI | 4422.5 AUD 2927.06 USD |
+0.09
|
— — | 4418.5 AUD 2924.42 USD | 4436.7 AUD 2936.46 USD | — - | — — |
| S&P/ASX 50 AFLI | 7691.9 AUD 5090.94 USD |
+0.03
|
— — | 7689.8 AUD 5089.55 USD | 7718.6 AUD 5108.61 USD | — - | — — |
| NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
| S&P/ASX 200 Net Total Rtn AXNT | 94469.1 AUD 62525.05 USD |
-0.05
|
— — | 94469.1 AUD 62525.05 USD | 94848.1 AUD 62775.9 USD | — - | — — |
| S&P/ASX 200 AXJO | 7848.1 AUD 5194.32 USD |
-0.05
|
— — | 7848.1 AUD 5194.32 USD | 7879.6 AUD 5215.17 USD | — - | — — |
| S&P/ASX ALL AUSTRALIAN 200 AXAT | 7855.5 AUD 5199.22 USD |
-0.04
|
— — | 7855.5 AUD 5199.22 USD | 7887.6 AUD 5220.46 USD | — - | — — |
| S&P/ASX 100 ATOI | 6587.3 AUD 4359.85 USD |
<0.01
|
— — | 6587.3 AUD 4359.85 USD | 6610.7 AUD 4375.34 USD | — - | — — |
| ALL ORDINARIES AORD | 8118.3 AUD 5373.16 USD |
-0.02
|
— — | 8118.3 AUD 5373.16 USD | 8150.6 AUD 5394.53 USD | — - | — — |
| Nasdaq Developed Select Leaders NQDMSLC | 1260.81 USD — |
0
|
— — | 1243.71 USD — | 1264.94 USD — | — - | — — |
- {{ link.label }} {{link}}